CIRCULATING TUMOR CELLS (CTC) AND ARTIFICIAL NEURAL NETWORK (ANN) IN METASTATIC BREAST CANCER (MBC) PATIENTS

被引：0
|
作者：
Giordano, A. [1 ]
Giuliano, M. [1 ]
De Laurentiis, M. [2 ]
Eleuteri, A. [3 ]
Iorio, F. [4 ]
Tagliaferri, R. [5 ]
Reuben, J. [6 ]
Hortobagyi, G. N. [1 ]
de Placido, S. [7 ]
Cristofanilli, M. [8 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Naples Federico 2, Dept Endocrinol & Mol Oncol, Naples, Italy
[3] Royal Liverpool Univ Hosp, Med Phys & Clin Engn, Liverpool, Merseyside, England
[4] TeleThon Inst Genet & Med, Syst Synthet & Computat Lab, Naples, Italy
[5] Univ Salerno, Neurone Lab, Fisciano, Italy
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Univ Naples Federico 2, Naples, Italy
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25O
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients
    Paoletti, Costanza
    Cani, Andi K.
    Aung, Kimberly
    Darga, Elizabeth P.
    Cannell, Emily M.
    Hovelson, Daniel H.
    Yazdani, Maryam
    Blevins, Allen R.
    Tokudome, Nahomi
    Baratta, Paul J.
    Larios, Jose' M.
    Thomas, Dafydd G.
    Brown, Martha E.
    Gersch, Christina
    Schott, Anne F.
    Robinson, Daniel
    Chinnaiyan, Arul M.
    Bischoff, Farideh
    Hayes, Daniel F.
    Rae, James M.
    Tomlins, Scott A.
    [J]. CANCER RESEARCH, 2016, 76
  • [2] Somatic genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients
    Paoletti, C.
    Cani, A. K.
    Aung, K.
    Darga, E. P.
    Cannell, E. M.
    Hovelson, D. H.
    Yazdani, M.
    Blevins, A. R.
    Tokudome, N.
    Larios, J. M.
    Thomas, D. G.
    Brown, M. E.
    Gersch, C.
    Schott, A. F.
    Robinson, D. R.
    Chinnaiyan, A. M.
    Bischoff, F.
    Hayes, D. F.
    Rae, J. M.
    Tomlins, S. A.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients
    Antonio Giordano
    Mario Giuliano
    Michelino De Laurentiis
    Antonio Eleuteri
    Francesco Iorio
    Roberto Tagliaferri
    Gabriel N. Hortobagyi
    Lajos Pusztai
    Sabino De Placido
    Kenneth Hess
    Massimo Cristofanilli
    James M. Reuben
    [J]. Breast Cancer Research and Treatment, 2011, 129 : 451 - 458
  • [4] Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients
    Giordano, Antonio
    Giuliano, Mario
    De Laurentiis, Michelino
    Eleuteri, Antonio
    Iorio, Francesco
    Tagliaferri, Roberto
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    De Placido, Sabino
    Hess, Kenneth
    Cristofanilli, Massimo
    Reuben, James M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 451 - 458
  • [5] Circulating tumor cells (CTC): Assessment of treatment efficacy in metastatic breast cancer (MBC)
    Liu, M. C.
    Shields, P.
    Isaacs, C.
    Warren, R.
    Cohen, P.
    Wilkinson, M.
    Zhang, Y.
    Shen, R.
    Luyegu, K.
    Gallagher, A. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Prognostic impact of changes in circulating tumor cells (CTC) in metastatic breast cancer (MBC)
    Wallwiener, Markus
    Hartkopf, Andreas D.
    Riethdorf, Sabine
    Sprick, Martin
    Domschke, Christoph Wolfram
    Schott, Sarah
    Baccelli, Irene
    Modugno, Caroline
    Schoenfisch, Birgitt
    Burwinkel, Barbara
    Marme, Frederik
    Heil, Joerg
    Sohn, Christof
    Pantel, Klaus
    Trumpp, Andreas
    Schneeweiss, Andreas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Circulating tumor cells (CTC): A reliable predictor of treatment efficacy in metastatic breast cancer (MBC)
    Liu, M. C.
    Isaacs, C.
    Warren, R.
    Cohen, P.
    Wilkinson, M.
    Ottaviano, Y.
    Rao, S.
    Zhang, Y.
    Gallagher, A.
    Shields, P. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC).
    Budd, GT
    Cristofanilli, M
    Ellis, MJ
    Stopeck, A
    Matera, J
    Miller, MC
    Doyle, GV
    Allard, WJ
    Terstappen, LW
    Hayes, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 4S - 4S
  • [9] Correlation of Circulating Tumor Cells (CTC) with Clinical Characteristics, Pathological Factors, and Treatment Response in Patients with Metastatic Breast Cancer (MBC)
    Bayable, Asnakech
    Wang, Tingchang
    Blackford, Amanda
    Tao, Jessica
    Canzoniero, Jenna
    Lee, Seoho
    Too, Faith
    Blouw, Barbara
    Wilkinson, Mary
    Couzi, Rima
    Wolff, Antonio
    Hiton, Christie
    Park, Ben
    Stearns, Vered
    Santa-Maria, Cesar
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [10] Assessment of circulating tumor cells (CTC) by RT/PCR as a surrogate marker for PFS in metastatic breast cancer (MBC)
    Saber, M. M.
    Bahnasy, A. A.
    EI-Zawahry, H. M.
    Allahloubi, N. M.
    El-Moetii, M. A.
    Abd El Fatah, R. M.
    Aid, S.
    Ghareeb, M.
    [J]. CANCER RESEARCH, 2013, 73
12345